In this webinar, MedCrypt CEO Mike Kijewski and FDA expert Naomi Schwartz share their thoughts on the FDA's new Refuse to Accept (RTA) guidance. In March 2023, following the December 2022 Omnibus bill passed by Congress, the FDA released its RTA Cybersecurity guidance. This stipulated that after October 2023, any medical device manufacturer that fails to meet specific cybersecurity rules would have its products rejected by the FDA.
Our team of FDA analysts and cybersecurity experts provide robust and actionable cybersecurity roadmaps to ensure you meet FDA requirements. Get the Medcrypt advantage today!
Sr Director of Cybersecurity Quality and Safety
Research, not marketing
We are dedicated to helping advance our industry’s understanding of the challenges and opportunities we face through research. Check out our whitepapers.